Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of BOTOX in neurogenic detrusor overactivity with urinary incontinence
2007-000192-42Phase 3Completed
- Sponsor
- Allergan
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in detrusor hyperreflexia (DH) and urinary incontinence (UI) (3 arms), sponsored by Allergan. Primary endpoint: Primary efficacy assessment. Started Apr 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
detrusor hyperreflexia (DH)urinary incontinence (UI)
Beyond the preview
Go deeper on 2007-000192-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000192-42.